Dermal Filler Market Size, Share, Trends, Growth 2030

Dermal Filler Market Size:

The global dermal filler market size was worth around USD 4.8 Billion in 2021 and is predicted to grow to around USD 11.7 Billion by 2030 with a compound annual growth rate (CAGR) of roughly 10.5% between 2022 and 2030.

The report analyzes the global dermal filler market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the dermal filler market.

Request Free Sample

Get more information about this report - Request Free Sample PDF

Dermal Filler Market: Overview

Less invasive procedures called dermal fillers are utilized as anti-aging treatments to reduce facial lines and restore firmness. These soft tissue fillers known as dermal fillers, which include hyaluronic acid, polymers and particles, and collagen, are injected into the skin to address conditions including scars & wrinkles and smoothen the skin. A range of skin-related problems is treated with dermal filler procedures. Techniques using dermal fillers can be used to smooth skin, get rid of scars and wrinkles, and perform other operations.

Key Insights

• As per the analysis shared by our research analyst, the global dermal filler market is estimated to grow annually at a CAGR of around 10.5% over the forecast period (2022-2030).
• In terms of revenue, the global dermal filler market size was valued at around USD 4.8 billion in 2021 and is projected to reach USD 11.7 billion, by 2030.
• The demand for minimally invasive aesthetic procedures, the increase in plastic surgeons performing aesthetic procedures, and the availability of reasonably priced alternatives to cosmetic surgery are the main factors driving the market for dermal fillers.
• Based on the type, the biodegradable segment accounted for the largest market share in 2021.
• Based on the application, the wrinkle correction treatment segment maintained the greatest revenue market share in 2021.
• Based on region, North America is expected to dominate the market during the forecast period.

Request Free Sample

To know more about this report, request a sample copy.

Dermal Filler Market: Growth Drivers

Growing demand for less invasive procedures to drive the market growth

One or more minimally invasive procedures, such as neurotoxins, Dermal Fillers, deoxycholic acid, lasers, peels, and microneedling, can be effective, less invasive alternatives to surgery for some patients. Injectables and skin resurfacing techniques are used to treat a variety of facial problems, including wrinkles, fine lines, loss of volume and contour, and excess fat.

The ideal treatment strategy for a given patient must carefully take into account the patient's medical issues, unique anatomical features, tissue quality, and anticipated outcomes. An article on facial plastic surgery estimates that 1.4 million surgical and non-surgical procedures will be carried out worldwide in 2021, with plastic doctors doing an additional 600 operations per year on average. Comparing the statistics revealed a 40% increase to the previous year.

Dermal Filler Market: Restraints

The high cost of treatment limits the market growth                                                             

Dermal filler cosmetic therapy is a well-liked and secure outpatient method for treating minor volume loss and aging signs. However, it is anticipated that the expensive price will hinder the global dermal filler market demand for these treatments. According to the American Society of Plastic Surgeons, PMMA [Poly (Methyl Methacrylate)] costs $981, Calcium Hydroxylapatite costs $717, Fat Fillers cost $2,508, Hyaluronic Acid costs $684, Poly-L-lactic Acid costs $853, and polymethyl-methacrylate microspheres cost $1,058. Depending on the type and quantity used during treatment, dermal filler prices can vary. Thus, the high cost of treatments is expected to impede market growth over the forecast period.

Dermal Filler Market: Opportunities

Innovation in dermal fillers provides a lucrative opportunity

Dermal fillers are gel-like materials that are injected beneath the skin to replenish lost volume, smooth out wrinkles, and soften lines. More than a million people choose this well-known cosmetic transformation procedure each year to remove wrinkles and improve the appearance of facial lines to enhance facial features. Dermal fillers are a successful procedure that can make you seem younger without surgery or recovery time. Dermal fillers are medications that are injected beneath the skin to fill in face creases. Dermal filler medications come in a variety of forms, the most popular being calcium hydroxylapatite, hyaluronic acid, polyalkylimide, polylactic acid, and others. Dermal filler brand advancement will support increased market demand.

Dermal Filler Market: Challenges

The dearth of skilled professionals acts as a major challenge

There are many different types of aesthetic treatment methods, including laser-based technology, energy-based technology, and powerful pulse light. For any of these techniques to be used effectively, the practitioner must possess strong interpersonal skills. Additionally, the field's rapid technological development has resulted in a shortage of qualified specialists. The handling of surgical instruments and performing procedures are both significantly hampered by a lack of competent experts.

Dermal Filler Market: Segmentation

The global dermal filler market is segmented based on type, material type, application, end-user, and region.

Based on the type, the global market is bifurcated into biodegradable and non-biodegradable. The biodegradable segment accounted for the largest market share in 2021 and is expected to show its dominance during the forecast period. The growth in the segment is attributed to the more product options being offered, as well as the increasing usage of biodegradable materials for aesthetic purposes. Biodegradable products are created entirely of natural materials and are applied topically to the skin, hair, face, and mouth. On the other hand, the non-biodegradable segment is projected to grow at the fastest CAGR during the forecast period.

The growth in the non-biodegradable segment is attributed to the product's long-lasting quality. Non-biodegradable substances do not degrade and remain in the body for a longer period than temporary and semi-permanent fillers.

Based on the material type, the dermal filler industry is bifurcated into hyaluronic acid, calcium hydroxylapatite, poly-l-lactic acid, PMMA [Poly (Methyl Methacrylate)], and others.

Based on the application, the global dermal filler is divided into facial line correction treatment, face-lift, scar treatment, wrinkle correction treatment, lip enhancement, and others. The wrinkle correction treatment segment maintained the greatest revenue market share in 2021, owing to increased demand for these treatments among the aging population. According to Cosmetic Executive Women (CEW) news from 2021, an average of 943,500 searches for aging-related concerns in the skin care area are conducted in the United States each month. Besides, the Lip Enhancement category is expected to develop at the quickest CAGR throughout the projected period, owing to the increasing frequency of lip treatments and the growing demand for cosmetic lip enhancements.

Based on the end user, the global market is segmented into dermatology clinics, hospitals, and others.

Recent Developments:

• In November 2021, The virtual American Society for Dermatologic Surgery (ASDS) 2021 Annual Meeting was held November 19–21, 2021, and Galderma announced that data supporting its aesthetics portfolio and pipeline would be presented there. One oral presentation of an abstract on the safety of hyaluronic acid (HA) filler was among the eight abstracts from investigator-initiated and Galderma-sponsored trials that were accepted.
• In April 2022, Sinclair Pharma announced that its Perfectha Lidocaine wrinkle-reduction, facial contouring, and volume-restoration solutions have earned the European Certification mark. Now accessible in the UK and all significant European markets are Perfectha Lidocaine.

Dermal Filler Market Report Scope:

To know more about this report, request a sample copy.

Dermal Filler Market: Regional Analysis

North America is expected to dominate the market during the forecast period

Throughout the predicted period, North America is anticipated to rule the global dermal filler market. An extremely aware and financially secure people is one component of this region's supremacy. For instance, 15.6 million cosmetic treatments were carried out in the United States in 2020, according to the American Society of Plastic Surgeons (ASPS). Additionally, the region's growth is anticipated to be fueled by new product releases and regulatory clearances during the projected period.

For instance, The US Food and Drug Administration (FDA) declared RHA Redensity to be approved. RHA Redensity, a gel implant or dermal filler made by the Swiss hyaluronic acid product manufacturer Teoxane, is injected into particular areas of facial tissue to minimize the appearance of lines and wrinkles. Sodium hyaluronic acid (NaHA), 1,4-butanediol diglycidyl ether (BDDE), and 0.3% of the medication lidocaine hydrochloride are included in it. Thus, the fast product approval by the regulatory authorities will flourish the market expansion over the forecast period.

The second-highest market share is expected to be held by Europe, which can be attributed to rising consumer interest in Dermal Fillers procedures in important European countries and rising R&D spending there. However, it is anticipated that the Asia Pacific region will have phenomenal growth during the predicted period. The region's market is expanding due to the improved healthcare infrastructure in Asian countries, the rapidly aging population, and the increasing awareness of people about their physical presence. For instance, as per World Health Organization (WHO), in the South-East Asia Region, the population is aging quickly. While the percentage of adults 60 and older was 9.8% in 2017, it will rise to 13.7% and 20.3%, respectively, by 2030 and 2050.

Dermal Filler Market: Competitive Analysis

The global dermal filler market is dominated by players like:

• Prollenium Medical Technologies
• Suneva Medical
• Revance Therapeutics Inc.
• Anika Therapeutics Inc
• FillMed Laboratories
• Ipsen Pharma
• BIOXIS Pharmaceuticals
• Zhejiang Jingjia Medical Technology Co. Ltd.
• Zimmer Aesthetic
• Medytox
• Contura International ltd.
• Shanghai Reyoungel Medical Technology Company Limited
• Galderma Laboratories
• L.P.
• Croma-Pharma GmbH
• Teoxane
• BioPlus Co. Ltd.

The global dermal filler market is segmented as follows:

By Type

• Biodegradable
• Non-biodegradable

By Material Type

• Hyaluronic Acid
• Calcium Hydroxylapatite
• Poly-L-lactic Acid
• PMMA [Poly (Methyl Methacrylate)]
• Others

By Application

• Facial Line Correction Treatment
• Face-Lift
• Scar Treatment
• Wrinkle Correction Treatment
• Lip Enhancement
• Others

By End User

• Dermatology Clinics
• Hospitals
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa